EP3291798A4 - A freeze dried pharmaceutical formulation of rifabutin and process for preparation thereof - Google Patents
A freeze dried pharmaceutical formulation of rifabutin and process for preparation thereof Download PDFInfo
- Publication number
- EP3291798A4 EP3291798A4 EP15891266.7A EP15891266A EP3291798A4 EP 3291798 A4 EP3291798 A4 EP 3291798A4 EP 15891266 A EP15891266 A EP 15891266A EP 3291798 A4 EP3291798 A4 EP 3291798A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- rifabutin
- preparation
- pharmaceutical formulation
- freeze dried
- dried pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- ZWBTYMGEBZUQTK-PVLSIAFMSA-N [(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,32-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-1'-(2-methylpropyl)-6,23-dioxospiro[8,33-dioxa-24,27,29-triazapentacyclo[23.6.1.14,7.05,31.026,30]tritriaconta-1(32),2,4,9,19,21,24,26,30-nonaene-28,4'-piperidine]-13-yl] acetate Chemical compound CO[C@H]1\C=C\O[C@@]2(C)Oc3c(C2=O)c2c4NC5(CCN(CC(C)C)CC5)N=c4c(=NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)c(O)c2c(O)c3C ZWBTYMGEBZUQTK-PVLSIAFMSA-N 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 229960000885 rifabutin Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1770MU2015 | 2015-05-04 | ||
| PCT/IN2015/000348 WO2016178240A1 (en) | 2015-05-04 | 2015-09-07 | A freeze dried pharmaceutical formulation of rifabutin and process for preparation thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP3291798A1 EP3291798A1 (en) | 2018-03-14 |
| EP3291798A4 true EP3291798A4 (en) | 2019-01-16 |
Family
ID=57218191
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP15891266.7A Withdrawn EP3291798A4 (en) | 2015-05-04 | 2015-09-07 | A freeze dried pharmaceutical formulation of rifabutin and process for preparation thereof |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP3291798A4 (en) |
| EA (1) | EA201792417A1 (en) |
| WO (1) | WO2016178240A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2020344214A1 (en) | 2019-09-12 | 2022-04-21 | BioVersys AG | Antibiotic combination therapies |
| MX2022003075A (en) * | 2019-09-12 | 2022-07-11 | BioVersys AG | TREATMENT METHODS, USES AND COMPOSITIONS OF RIFABUTIN. |
| US11344537B2 (en) | 2019-09-18 | 2022-05-31 | BioVersys AG | Rifabutin treatment methods, uses, and compositions |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA013569B1 (en) * | 2009-02-24 | 2010-06-30 | Ооо "Научно-Производственный Комплекс "Наносистема"" | Pharmaceutical composition of rifabutin for treating tuberculosis and other diseases mediated by helicobacter pylori, method of production thereof and method for treatment thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2550811C (en) * | 2003-12-24 | 2012-05-01 | Jane Hirsh | Temperature-stable formulations, and methods of development thereof |
| RU2327457C1 (en) * | 2007-06-26 | 2008-06-27 | Автономная некоммерческая организация "Институт молекулярной диагностики" (АНО "ИнМоДи") | Medicinal agent based on rybafutin, agent of antimicrobic action containing nanoparticles, and related method of production |
| NZ587250A (en) * | 2008-02-08 | 2011-12-22 | Red Hill Biopharma Ltd | Methods and compositions for treating inflammatory bowel disease |
-
2015
- 2015-09-07 EP EP15891266.7A patent/EP3291798A4/en not_active Withdrawn
- 2015-09-07 WO PCT/IN2015/000348 patent/WO2016178240A1/en not_active Ceased
- 2015-09-07 EA EA201792417A patent/EA201792417A1/en unknown
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA013569B1 (en) * | 2009-02-24 | 2010-06-30 | Ооо "Научно-Производственный Комплекс "Наносистема"" | Pharmaceutical composition of rifabutin for treating tuberculosis and other diseases mediated by helicobacter pylori, method of production thereof and method for treatment thereof |
Non-Patent Citations (1)
| Title |
|---|
| See also references of WO2016178240A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2016178240A1 (en) | 2016-11-10 |
| EP3291798A1 (en) | 2018-03-14 |
| EA201792417A1 (en) | 2018-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL261989A (en) | A pharmaceutical formulation of palbociclib and a preparation method thereof | |
| EP3139920A4 (en) | Anti-viral compounds, pharmaceutical compositions, and methods of use thereof | |
| EP3130354A4 (en) | Posaconazole pharmaceutical composition and preparation method, application and pharmaceutical preparation thereof | |
| IL258922A (en) | Methods for the preparation of obeticholic acid and derivatives thereof | |
| EP3295952A4 (en) | Pharmaceutical formulation comprising glp-1 analogue and preparation method thereof | |
| EP3297640A4 (en) | Pharmaceutical co-crystal composition and use thereof | |
| EP3093023A4 (en) | Pharmaceutical composition for cancer treatment and pharmaceutical preparation for cancer treatment containing same composition as active ingredient | |
| EP3429589A4 (en) | Pharmaceutical composition of nilotinib | |
| PT2957280T (en) | Solid pharmaceutical composition of cytisine and process for preparation thereof | |
| SG10202008700VA (en) | α-TRUXILLIC ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THEREOF | |
| EP3216450A4 (en) | Pharmaceutical preparation comprising cyclin inhibitor and preparation method thereof | |
| EP3291798A4 (en) | A freeze dried pharmaceutical formulation of rifabutin and process for preparation thereof | |
| EP3522889A4 (en) | Delayed release pharmaceutical composition of pantoprazole and process for preparation thereof | |
| EP3307294A4 (en) | Pharmaceutical composition for treatment of depression and preparation method thereof | |
| GB201718483D0 (en) | Pharmaceutical composition for treatment of meopausal syndrome and preparation method thereof | |
| PL3331497T3 (en) | A lubricant formulation of carbamoylethyl katira and a process for preparation thereof | |
| EP3154528A4 (en) | Spray dried compositions having different dissolution profiles and processes for their preparation | |
| IL266938A (en) | Pharmaceutical preparation and method for its manufacture | |
| HK40039835B (en) | A pharmaceutical formulation of palbociclib and a preparation method thereof | |
| HK40039835A (en) | A pharmaceutical formulation of palbociclib and a preparation method thereof | |
| HK40100474A (en) | Process for preparation of compound and its purification for use as active pharmaceutical ingredient | |
| HK40099449A (en) | Process for preparation of compound and its purification for use as active pharmaceutical ingredient | |
| HK40099431A (en) | Process for preparation of compound and its purification for use as active pharmaceutical ingredient | |
| IL253788A0 (en) | Pharmaceutical formulation of racecadotril | |
| HK40003698B (en) | A pharmaceutical formulation of palbociclib and a preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20171106 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| AX | Request for extension of the european patent |
Extension state: BA ME |
|
| DAV | Request for validation of the european patent (deleted) | ||
| DAX | Request for extension of the european patent (deleted) | ||
| A4 | Supplementary search report drawn up and despatched |
Effective date: 20181217 |
|
| RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 31/435 20060101ALI20181207BHEP Ipc: A61K 9/19 20060101AFI20181207BHEP Ipc: A61K 47/26 20060101ALI20181207BHEP |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20190719 |